Peter James Krause MD

Senior Research Scientist in Epidemiology (Microbial Diseases), in Medicine (Infectious Diseases) and in Pediatrics (Infectious Disease) and Lecturer in Epidemiology (Microbial Diseases)

Research Interests

Vector borne diseases


Research Summary

Dr. Krause’s research interests are in vector borne diseases including babesiosis, Lyme disease and Borrelia miyamotoi, a relapsing fever spirochete. Current projects include babesiosis and Lyme disease persistence, co-infection, and geographic expansion; the host immunologic response to Babesia microti; prevention of transmission of babesiosis through blood transfusion; and human infection with Borrelia miyamotoi.

Extensive Research Description

Dr. Krause’s research interests are in vector borne diseases including babesiosis, Lyme disease and Borrelia miyamotoi, a relapsing fever spirochete. Current projects include babesiosis and Lyme disease persistence, co-infection, and geographic expansion; the host immunologic response to Babesia microti; prevention of transmission of babesiosis through blood transfusion; and human infection with Borrelia miyamotoi.


Selected Publications

  • Vannier E and Krause PJ. Babesiosis in China, an emerging threat. Lancet Infect Dis 2015;15:137-9.
  • Dunn J-Krause PJ*, Davis S, Vannier E, Fitzpatrick M, Rollend L, Belperron A, States S, Stacey A, Bockenstedt L, Fish D, Diuk-Wasser M. Borrelia burgdorferi promotes the establishment of Babesia microti in the northeastern United States. PLoS One 2014;9:e115494.doi: 10.1371/journal.pone.0115494., *shared first authorship
  • Krause PJ, Narasimhan S, Wormser GP, Barbour AG, Platonov AE, Brancato J, Lepore T, Dardick K, Mamula M, Rollend L, Steeves TK, Diuk-Wasser M, Usmani-Brown S, Williamson P, Sarksyan DS, Fikrig E, Fish D. Tick Borne Diseases Group. Borrelia miyamotoi sensu lato seroreactivity and seroprevalence in the northeastern United States. Emerging Infectious Diseases 2014;20:1183-90
  • Krause PJ, Narasimhan S, Wormser GP, Rollend L, Fikrig E, Lepore T, Barbour A, Fish D. Human Borrelia miyamotoi infection in the United States. New England Journal of Medicine 2013;368:291-3.
  • Vannier E and Krause PJ. Human Babesiosis. New England Journal of Medicine 2012;366:2397-407
  • Young C, Chawla A, Berardi V, Padbury J, Skowron G, Krause PJ. Preventing transfusion transmitted babesiosis: Preliminary experience of the first laboratory-based blood donor screening program. Transfusion 2012;52:1523-29.
  • Platonov AE, Karan LS, Kolyasnikova NM, Makhneva NA, Toporkova MG, Maleev VV, Fish D, Krause PJ. Human Infection with the relapsing fever spirochete Borrelia miyamotoi. Emerg Inf Dis, 2011,17:1816-1823.
  • Krause PJ, McKay K, Gadbaw J, et al: Increasing health burden of human babesiosis in endemic sites. American Journal of Tropical Medicine and Hygiene 2003;68:431-6.
  • Krause PJ, Lepore T, Sikand VK, et al. Atovaquone and azithromycin for the treatment of human babesiosis. New England Journal of Medicine 343:1454-1458, 2000
  • Krause PJ, Spielman A, Telford S, et al. Persistent parasitemia following acute babesiosis. New England Journal of Medicine, 339: 160-165, 1998

Edit Profile